ZY
Zhengye Biotechnology Holding Limited
ZYBT · NASDAQ
$1.37 -2.84% (-$0.04)
1M -29.74%
Market Cap ¥434.2M
P/E Ratio -
Div. Yield -
ROE 25.78%
Valuation
32 /100
Expensive P/B 1.74x
P/FCF 617.70x
P/S 3.73x
Growth
0 /100
Declining Book val. growth 5.55%
Rev. growth 23.53%
FCF growth N/A
Profitability
9 /100
Weak Net margin 59.97%
Op. margin 58.66%
FCF margin 0.60%
Quality
3 /100
Poor ROE 25.78%
ROA 15.99%
Asset turnover 0.27x
Debt
57 /100
Moderate Current ratio 1.14x
Int. coverage -20.14x
Debt/Equity 0.30x
Stability
55 /100
Moderate Rev. volatility 13.28%
EPS volatility 33.86%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ZYBT
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Songlin Song
Employees
269
Headquarters
Jilin